The company expired its plan on May 26, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.2 SEK | -0.65% | 0.00% | -0.43% |
23/02 | Initiator Pharma A/S Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 | CI |
21/02 | Initiator Pharma Issues New Shares for Debt Conversion | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-0.43% | 45.1M | |
+19.02% | 47.02B | |
+48.77% | 41.86B | |
+0.22% | 41.76B | |
-4.27% | 28.8B | |
+11.58% | 26.05B | |
-22.03% | 19.15B | |
+4.13% | 12.55B | |
+29.25% | 12.34B | |
-4.65% | 11.82B |
- Stock Market
- Equities
- INIT Stock
- News Initiator Pharma A/S
- Initiator Pharma A/S's Equity Buyback announced on July 25, 2022 has expired.